🤖 AI, DIGITAL TWINS & COMPUTATIONAL LONGEVITY AT THE LIMIT Artificial Intelligence, Personal Digital Twins, Causal Simulation, Single-Cell Models, Virtual Trials, and the Future of Computational Healthspan Engineering

Abstract

🤖 AI, DIGITAL TWINS & COMPUTATIONAL LONGEVITY AT THE LIMIT Artificial Intelligence, Personal Digital Twins, Causal Simulation, Single-Cell Models, Virtual Trials, and the Future of Computational Healthspan Engineering Can we test part of a 30-year longevity intervention before waiting 30 years? This flagship research volume explores what happens when longevity science becomes increasingly computational. Modern aging research produces enormous amounts of information: genomics,epigenomics,proteomics,metabolomics,medical imaging,single-cell data,spatial biology,wearables,clinical records,environmental exposures,intervention histories,and decades of longitudinal health trajectories. The challenge is no longer only how to collect more data. The deeper challenge is how to transform these signals into models that can explain, simulate, test, and eventually help guide meaningful healthspan research. The central computational vision of this book is: Human→Longitudinal Data→Digital Twin→Simulation→Intervention→Feedback This cycle represents a future research architecture in which human biological state is repeatedly measured, computationally modeled, experimentally challenged, updated with new evidence, and continuously recalibrated. The goal is not to create a perfect virtual copy of a person. It is to build increasingly useful models of biological trajectories, intervention responses, uncertainty, resilience, and risk. The book develops this vision across several major research domains: AI AGING FOUNDATION MODELS Multimodal models integrating molecular biology, imaging, clinical history, wearables, physiology, and longitudinal data. PERSONAL LONGEVITY DIGITAL TWINS Dynamic computational representations of individual health trajectories, exposures, physiological states, intervention histories, and recovery patterns. CAUSAL AI Models designed not only to predict what may happen, but to ask what could change if a specific intervention were applied. COUNTERFACTUAL AGING Research frameworks for estimating alternative biological trajectories: What might have happened without an intervention? What might happen under a different intervention? Which observed changes are causal rather than merely correlated? SINGLE-CELL AND SPATIAL INTELLIGENCE Foundation models, cellular-state maps, tissue atlases, spatial omics, and computational representations of aging at cellular and tissue scales. ORGANOID–AI LOOPS Experimental systems in which organoids, tissue chips, and computational models repeatedly inform one another. GENERATIVE LONGEVITY DISCOVERY AI-assisted target discovery, virtual screening, generative chemistry, candidate prioritization, and hypothesis generation for geroscience. VIRTUAL GEROSCIENCE TRIALS Simulation, synthetic control arms, target-trial emulation, Bayesian adaptive methods, surrogate endpoint research, and computational approaches to long-duration intervention design. WEARABLE AND CONTINUOUS PHENOTYPING Longitudinal signals from movement, sleep, cardiovascular dynamics, activity, recovery, and other continuously measurable human states. CLOSED-LOOP INTERVENTIONS Systems in which measurement, modeling, intervention, feedback, and model updating occur repeatedly rather than as isolated events. One of the central questions of the book is: Can part of a 30-year longevity intervention be tested before waiting 30 years? The answer cannot simply be “simulate everything.” Simulation does not replace biological reality. A digital twin does not automatically become evidence. A prediction is not the same as a causal effect. A synthetic control is not automatically equivalent to a randomized trial. And an AI-generated hypothesis is not a validated healthspan intervention. Instead, computational longevity must be built as an evidence-linked system. Simulation may help reduce the search space. Digital twins may help generate testable hypotheses. Causal models may help identify competing explanations. Synthetic controls may improve trial design. Single-cell models may reveal hidden state transitions. Wearables may shorten feedback loops. Organoid–AI systems may allow faster experimental iteration. But each layer must eventually reconnect to biological experiments, human outcomes, uncertainty, safety, and longitudinal validation. The book therefore treats AI as an accelerator of research rather than a substitute for evidence. A central principle is: Simulation can compress parts of the search,but it cannot erase evidence that has not yet been earned. This principle becomes especially important in longevity research because many outcomes unfold across years or decades. Models will drift. Populations will change. Measurement technologies will change. Interventions will change. Human behavior will change. A digital twin that performs well today may become poorly calibrated years later. For this reason, long-horizon computational longevity requires: continuous recalibration,model-version tracking,uncertainty estimation,external validation,population fairness,privacy protection,failure detection,and human oversight. The book also explores the possibility that future longevity research may increasingly resemble a continuously learning experimental ecosystem. Human observations inform models. Models generate hypotheses. Hypotheses guide experiments. Experiments update models. New data revise intervention strategies. And the entire system becomes more precise through repeated feedback. The objective is not computational certainty. It is structured uncertainty reduction. Designed as a large-scale Living Interactive research volume, the book contains 200 Research Gates. Each Gate represents an unresolved research space rather than a final conclusion. The Gates explore: AI aging foundation models,federated longevity datasets,generative drug discovery,personal digital twins,causal intervention models,single-cell foundation models,spatial aging maps,organoid–AI loops,tissue-chip validation,wearable phenotyping,synthetic control arms,virtual geroscience trials,target-trial emulation,Bayesian adaptive trials,mechanistic simulations,closed-loop interventions,surrogate endpoints,model drift across decades,privacy-preserving analytics,and human oversight of AI-generated longevity hypotheses. The purpose of these Research Gates is not to claim that the future can already be predicted. It is to leave structured entrances into the unknown. From data,to models; from models,to simulation; from simulation,to hypotheses; from hypotheses,to experiments; from experiments,to evidence; from evidence,back into better models. AI, DIGITAL TWINS & COMPUTATIONAL LONGEVITY AT THE LIMIT ultimately asks whether longevity science can become not only more predictive, but more adaptive, causal, testable, and continuously learning. The long-term vision is not an algorithm that decides the future of a human life. It is a computational research ecosystem capable of helping future researchers explore more possibilities before exposing real people to unnecessary uncertainty. Feng Cheng-en (33) × Starli STARLI Arcane Research Edition 120K+ English200 Research GatesGoogle Books Living Interactive EditionSeptember 2026 33’s Shop of the Unknown We don’t sell certainty.We sell researchable unknowns.